AT317192B - Verfahren zur Herstellung von neuen Naphthylalkylaminen - Google Patents

Verfahren zur Herstellung von neuen Naphthylalkylaminen

Info

Publication number
AT317192B
AT317192B AT740171A AT740171A AT317192B AT 317192 B AT317192 B AT 317192B AT 740171 A AT740171 A AT 740171A AT 740171 A AT740171 A AT 740171A AT 317192 B AT317192 B AT 317192B
Authority
AT
Austria
Prior art keywords
naphthylalkylamines
preparation
new
new naphthylalkylamines
Prior art date
Application number
AT740171A
Other languages
English (en)
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Application granted granted Critical
Publication of AT317192B publication Critical patent/AT317192B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00—Silicon; Compounds thereof
    • C01B33/113—Silicon oxides; Hydrates thereof
    • C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
    • C01B33/14—Colloidal silica, e.g. dispersions, gels, sols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
AT740171A 1969-12-12 1970-12-11 Verfahren zur Herstellung von neuen Naphthylalkylaminen AT317192B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1962497A DE1962497C3 (de) 1969-12-12 1969-12-12 Naphthylalkyl- a -hydroxyphenäthyl-amine, ihre Herstellung und diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
AT317192B true AT317192B (de) 1974-08-12

Family

ID=5753745

Family Applications (3)

Application Number Title Priority Date Filing Date
AT1117570A AT299924B (de) 1969-12-12 1970-12-11 Verfahren zur Herstellung von neuen Naphthylalkylaminen
AT740171A AT317192B (de) 1969-12-12 1970-12-11 Verfahren zur Herstellung von neuen Naphthylalkylaminen
AT740071A AT302284B (de) 1969-12-12 1970-12-11 Verfahren zur Herstellung von neuen Naphthylalkylaminen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT1117570A AT299924B (de) 1969-12-12 1970-12-11 Verfahren zur Herstellung von neuen Naphthylalkylaminen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT740071A AT302284B (de) 1969-12-12 1970-12-11 Verfahren zur Herstellung von neuen Naphthylalkylaminen

Country Status (25)

Country Link
US (1) US3966814A (de)
JP (3) JPS5116420B1 (de)
KR (2) KR780000007B1 (de)
AR (2) AR194205A1 (de)
AT (3) AT299924B (de)
BE (1) BE760252A (de)
BG (1) BG17956A3 (de)
CH (1) CH556322A (de)
CS (3) CS151064B2 (de)
DE (1) DE1962497C3 (de)
DK (1) DK136526B (de)
ES (3) ES386345A1 (de)
FI (1) FI53301C (de)
FR (1) FR2081347B1 (de)
GB (1) GB1330188A (de)
HU (1) HU162736B (de)
IE (1) IE34807B1 (de)
IL (1) IL35840A (de)
NL (1) NL169583C (de)
NO (1) NO131126C (de)
PL (3) PL81424B1 (de)
RO (3) RO61132A (de)
SE (1) SE378101B (de)
SU (2) SU505349A3 (de)
YU (3) YU35753B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2187319B1 (de) * 1972-06-09 1975-06-20 Bottu Exploit Labo
AU501137B2 (en) * 1975-12-11 1979-06-14 Tanabe Seiyaku Co., Ltd. Benzyl alcohol derivatives
JPS53149940A (en) * 1977-06-02 1978-12-27 Tanabe Seiyaku Co Ltd Novel benzyl alcohol derivatives and their preparation
US4849453A (en) * 1983-01-31 1989-07-18 Eli Lilly And Company Growth promotion
US5250546A (en) * 1984-09-28 1993-10-05 Nippon Chemiphar Co., Ltd. Amino-alcohol derivatives and processes for their preparation
AU609209B2 (en) * 1987-11-13 1991-04-26 Glaxo Group Limited Phenethanolamine derivatives
US5194450A (en) * 1988-04-20 1993-03-16 Burroughs Wellcome Co. Anti-hypertensive sulfonanilides
GB8809314D0 (en) * 1988-04-20 1988-05-25 Wellcome Found Anti-hypertensive sulfonanilides
CA2300273A1 (en) * 1997-08-05 1999-02-18 Takao Itoh Amine derivatives and method for producing the same
NZ549535A (en) 2004-03-17 2010-11-26 Novartis Ag Use of aliskiren for treating renal and other disorders
AU2013202127B2 (en) * 2006-08-10 2014-06-12 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Preparation of (R,R-)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure
WO2008022038A1 (en) * 2006-08-10 2008-02-21 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Preparation of (r,r)-fenoterol and (r,r)- or (r,s)-fenoterol analogues and their use in treating congestive heart failure
US9492405B2 (en) 2010-03-10 2016-11-15 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas
JP6208031B2 (ja) * 2014-01-30 2017-10-04 東芝ライフスタイル株式会社 ブラシレスモータおよびその製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE894396C (de) * 1944-05-21 1953-10-26 Troponwerke Dinklage & Co Verfahren zur Herstellung von 1-(o-, m- oder p-Oxyphenyl)-1-oxy-2-aralkylamino-aethanen
US3135797A (en) * 1958-04-15 1964-06-02 Colgate Palmolive Co Aromatic amino antispasmodic compounds
US3139441A (en) * 1960-02-16 1964-06-30 Colgate Palmolive Co Alpha (3, 4 dihidroxy phenyl)-beta-(nu-3, 14'-methylenedioxy-phenyl)-alkylamino ethanols
NL300751A (de) * 1962-11-30 1900-01-01
GB1059968A (en) * 1964-01-20 1967-02-22 Ici Ltd Naphthalene derivatives
NL6401871A (de) * 1964-02-27 1965-08-30
GB1095378A (de) * 1965-06-22
DE1543372A1 (de) * 1966-10-18 1971-04-01 Boehringer Sohn Ingelheim Verfahren zur Herstellung von o-substituierten 3,4-Dioxyphenylalkanolaminen

Also Published As

Publication number Publication date
NO131126C (de) 1975-04-09
YU137978A (en) 1981-02-28
RO61132A (de) 1976-12-15
CH556322A (de) 1974-11-29
SE378101B (de) 1975-08-18
IE34807L (en) 1971-06-12
CS151063B2 (de) 1973-09-17
AR194205A1 (es) 1973-06-29
DE1962497A1 (de) 1971-06-16
SU417936A3 (de) 1974-02-28
YU35753B (en) 1981-06-30
JPS5138716B1 (de) 1976-10-23
DK136526C (de) 1978-03-28
AR198224A1 (es) 1974-06-07
NL169583B (nl) 1982-03-01
BG17956A3 (de) 1974-03-05
ES386345A1 (es) 1974-01-01
YU35867B (en) 1981-08-31
FR2081347A1 (de) 1971-12-03
RO61063A (fr) 1978-07-15
IE34807B1 (en) 1975-08-20
SU505349A3 (ru) 1976-02-28
US3966814A (en) 1976-06-29
NL7018031A (de) 1971-06-15
KR780000269B1 (en) 1978-07-24
BE760252A (fr) 1971-06-11
PL84354B1 (de) 1976-03-31
PL84355B1 (de) 1976-03-31
YU301070A (en) 1980-12-31
YU35868B (en) 1981-08-31
PL81424B1 (de) 1975-08-30
AT299924B (de) 1972-07-10
DK136526B (da) 1977-10-24
NL169583C (nl) 1982-08-02
FR2081347B1 (de) 1974-08-30
KR780000007B1 (en) 1978-03-04
CS151062B2 (de) 1973-09-17
JPS5221505B1 (de) 1977-06-10
DE1962497C3 (de) 1979-09-20
JPS5116420B1 (de) 1976-05-24
IL35840A (en) 1974-06-30
FI53301B (de) 1977-12-30
SU384229A3 (de) 1973-05-23
FI53301C (fi) 1978-04-10
CS151064B2 (de) 1973-09-17
AT302284B (de) 1972-10-10
ES395481A1 (es) 1973-12-16
DE1962497B2 (de) 1979-01-25
IL35840A0 (en) 1971-02-25
RO56808A (de) 1975-03-15
YU137878A (en) 1981-02-28
ES395482A1 (es) 1973-12-16
HU162736B (de) 1973-04-28
NO131126B (de) 1974-12-30
GB1330188A (en) 1973-09-12

Similar Documents

Publication Publication Date Title
AT303055B (de) Verfahren zur Herstellung von neuen β-Aryl-2-aminoalkoxy-styrolen
AT298452B (de) Verfahren zur Herstellung von neuen Aminoalkylphenolen
AT299924B (de) Verfahren zur Herstellung von neuen Naphthylalkylaminen
AT313292B (de) Verfahren zur Herstellung von neuen 4-heterosubstituierten Azetidinonen-(2)
AT295547B (de) Verfahren zur Herstellung von neuen 4-Acyloxy-azetidin-2-onen
AT317249B (de) Verfahren zur Herstellung von neuen Dialkyl-xanthin-Derivaten
CH520706A (de) Verfahren zur Herstellung von neuen Bezothiazepinderivaten
AT303751B (de) Verfahren zur Herstellung von neuen Amidophenylguanidinen
AT294110B (de) Verfahren zur Herstellung von neuen 6-Alkoxy-pyridaziniumverbindungen
AT305987B (de) Verfahren zur Herstellung von neuen Aminoketonen
CH529141A (de) Verfahren zur Herstellung von neuen 6-Hydrazino-Pyridazinen
AT293411B (de) Verfahren zur Herstellung von neuen 2-Alkyl-pyridazoniumverbindungen
CH540899A (de) Verfahren zur Herstellung von neuen Neriifolin-Derivaten
AT295485B (de) Verfahren zur Herstellung von neuen N-substituierten γ-Cyanbutyraldiminen
AT299925B (de) Verfahren zur Herstellung von neuen 1-Amino-anthrachinonen
AT296333B (de) Verfahren zur Herstellung von neuen 4-Oxaphosphorinanen
AT301053B (de) Verfahren zur Herstellung von neuen 14β-Hydroxy-15α-acyloxy-cardenoliden
AT299952B (de) Verfahren zur Herstellung von neuen substituierten 2-Azabicycloalkanen
AT296300B (de) Verfahren zur Herstellung von neuen 6-Alkoxy-5,6-dihydro-4H-pyranen
AT303255B (de) Verfahren zur Herstellung von neuen Acylaminopenicillansäuren
AT300216B (de) Verfahren zur Herstellung von neuen d-18-Methyl-17α-alkinyl-4-östren-17β-olen
AT305503B (de) Verfahren zur herstellung von neuem 9alpha-fluor-16-fluormethylen-prednisolon-21-oenanthat
CH518943A (de) Verfahren zur Herstellung von neuen Derivaten des p-Aminoalkyl-benzolsulfonamids
AT311306B (de) Verfahren zur Herstellung von neuen N-substituierten N-Thioformyl-hydroxylaminen
CH522698A (de) Verfahren zur Herstellung von neuen Polyacyloxalamidrazonen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee